GPX4 and neoplasm: Meanwhile, many studies suggest that Erastin (SLC7A11 inhibitor) or RSL3 (GPX4 inhibitor) could inhibit tumor progression and also increasing the chemotherapeutic effect of some chemotherapeutics [34].